Chemical Structure
MLN4924 Solution [905579-51-3]
AG-CS1-0103
Overview
- SupplierAdipoGen Life Sciences
- Product NameMLN4924 [NAE Inhibitor] Solution [905579-51-3]
- Delivery Days Customer10
- CAS Number905579-51-3
- CertificationResearch Use Only
- Estimated Purity>99%
- FormulationLiquid
- Molecular FormulaC21H25N5O4S
- Molecular Weight443.5
- Scientific DescriptionAdenosine 5-monophosphate (AMP) analog. Potent, selective and cell permeable inhibitor of Nedd8 E1 Activating Enzyme (NAE) (IC50=4.7nM). NEDD8 is an ubiquitin-like protein whose activity is required to activate cullin-RING ubiquitin E3 ligases (CRLs) responsible for the ubiquitination and proteasome-dependent turnover of certain substrates relevant to cancer cell survival. Anticancer agent with in vitro and in vivo activity. By inhibiting the Neddylation pathway this molecule disrupts cullin-RING ligase activity, leading to inhibition of proliferation or apoptotic death of various human tumor cells through the deregulation of S-phase DNA synthesis. Inhibits related enzymes ubiquitin-activating enzyme (UAE) and SUMO-activating enzyme (SAE) with IC50 values of 1.5 and 8.2microM, respectively. Angiogenesis inhibitor and autophagy inducer. Antiviral agent. Exhibited pronounced antiviral activity against mouse and human cytomegalovirus, herpes simplex virus (HSV)- 1 (including multi-drug resistant clinical isolates), HSV-2, adeno and influenza viruses. - Chemical. CAS: 905579-51-3. Formula: C21H25N5O4S. MW: 443.5. Potent, selective and cell-permeable inhibitor of Nedd8 E1 Activating Enzyme (NAE). By inhibiting the Neddylation pathway this molecule disrupts cullin-RING ligase activity, leading to inhibition of proliferation or apoptotic death of various human tumor cells through the deregulation of S-phase DNA synthesis.
- SMILES[H][C@@]1(C[C@H](O)[C@H](COS(N)(=O)=O)C1)N1C=CC2=C(N[C@H]3CCC4=CC=CC=C34)N=CN=C12
- Storage Instruction-20°C
- UNSPSC51202000
References
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer: T.A. Soucy, et al.; Nature 458, 7239 (2009)
- MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells: Y. Gu, et al.; Blood 123, 3269 (2014)